GUARD.ST

Guard Therapeutics International AB (publ) [GUARD.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

GUARD.ST Stock Summary

Top 10 Correlated ETFs

GUARD.ST

Top 10 Correlated Stocks

GUARD.ST

In the News

GUARD.ST Financial details

Company Rating
-
Market Cap
255.56M
Income
-112.62M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
12
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-125.48
Forward P/E
-
PEG
43.64
P/S
-
P/B
206.36
P/C
-
P/FCF
-2.76
Quick Ratio
5.19
Current Ratio
5.27
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-11.2
EPS next Y
-
EPS next Q
-
EPS this Y
-28.37%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-26.72%
-
-
-
-
SMA20
-16.75%
SMA50
-53.85%
SMA100
-38.87%
Inst Own
-
Inst Trans
-
ROA
-130%
ROE
-109%
ROC
-1.64%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.1-49.8
52W High
-72.45%
52W Low
+170%
RSI
47.06
Rel Volume
0.87
Avg Volume
11.32K
Volume
9.81K
Perf Week
9.31%
Perf Month
-16.67%
Perf Quarter
-44.58%
Perf Half Y
-41.84%
-
-
-
-
Beta
-0.02
-
-
Volatility
0.44%, 1.43%
Prev Close
2.66%
Price
13.5
Change
-2.17%

Something similar

Top by Market Cap
VOO
VFINX
VTSAX
MSFT
DHR-PB
Top Correlated ETFs
FCGI.TO
HDLV.DE
WTD9.DE
KWBE.L
RAYZ.L
Top Correlated Stocks
R66.DE
1970.HK
ACAST.ST
4AB.DE
CFYN.L
Similar Market Cap
NETC
1520.HK
SNM.V
NNGAX
IMMR

Company Profile

Healthcare Biotechnology
  • Volume Average 11.32K
  • Market Capitalization 255.56M
  • Employee 12
  • CEO Mr. Tobias Larsson Agervald
  • Headquarters Stockholm,SE
  • IPO Date 2013-04-03
  • Website https://guardtherapeutics.com

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.